Ausgabe 5/2017
Inhalt (28 Artikel)
PD-L2: A prognostic marker in chromophobe renal cell carcinoma?
Franziska Erlmeier, Wilko Weichert, Michael Autenrieth, Max Wiedemann, Andres Jan Schrader, Arndt Hartmann, Philipp Ivanyi, Sandra Steffens
ALK rearrangement in specific subtypes of lung adenocarcinoma: immunophenotypic and morphological features
Luciana Possidente, Matteo Landriscina, Giuseppe Patitucci, Ludovica Borgia, Vittoria Lalinga, Giulia Vita
Expressions of insulin-like growth factor receptor-1 and cezanne-1 in lung adenocarcinoma
Zhaofei Pang, Lixuan Cui, Nan Ding, Linhai Zhu, Xiao Qu, Wei Dong, Jiajun Du, Qi Liu
Prospective assessment of oral mucositis and its impact on quality of life and patient-reported outcomes during radiotherapy for head and neck cancer
Pierfrancesco Franco, Stefania Martini, Jacopo Di Muzio, Chiara Cavallin, Francesca Arcadipane, Monica Rampino, Oliviero Ostellino, Giancarlo Pecorari, Paolo Garzino Demo, Massimo Fasolis, Mario Airoldi, Umberto Ricardi
Dynamics of hormonal disorders following unilateral orchiectomy for a testicular tumor
Paweł J. Wiechno, Maria Kowalska, Jakub Kucharz, Małgorzata Sadowska, Wojciech Michalski, Grażyna Poniatowska, Joanna Jońska-Gmyrek, Joanna Rzymkowska, Karol Nietupski, Tomasz Demkow
Targeted next-generation sequencing identified novel mutations in triple-negative myeloproliferative neoplasms
Yu-Cheng Chang, Huan-Chau Lin, Yi-Hao Chiang, Caleb Gon-Shen Chen, Ling Huang, Wei-Ting Wang, Chun-Chia Cheng, Johnson Lin, Yi-Fang Chang, Ming-Chih Chang, Ruey-Kuen Hsieh, Shu-Jen Chen, Ken-Hong Lim, Yuan-Yeh Kuo
Validation of REM score to predict endometrial cancer in patients with ultrasound endometrial abnormalities: results of a new independent dataset
Francesco Plotti, Stella Capriglione, Corrado Terranova, Roberto Montera, Giuseppe Scaletta, Salvatore Lopez, Daniela Luvero, Antonelli Gianina, Alessia Aloisi, Pierluigi Benedetti Panici, Roberto Angioli
Identification and characterization of biomarkers and their functions for Lapatinib-resistant breast cancer
Liang Zhang, Yi Huang, Wenlei Zhuo, Yi Zhu, Bo Zhu, Zhengtang Chen
Real-world treatment patterns in advanced pancreatic neuroendocrine tumors in the era of targeted therapy: perspectives from an academic tertiary center and community oncology practices
Maurice Herring, Lynn Huynh, Mei Sheng Duh, Francis Vekeman, Audrey Tiew, Maureen Neary, Emily Bergsland
Detecting asymptomatic recurrence after radical cystectomy contributes to better prognosis in patients with muscle-invasive bladder cancer
Ayumu Kusaka, Shingo Hatakeyama, Shogo Hosogoe, Itsuto Hamano, Hiromichi Iwamura, Naoki Fujita, Ken Fukushi, Takuma Narita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Hiroyuki Ito, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Chikara Ohyama
Efficacy of neratinib in the treatment of HER2/neu-amplified epithelial ovarian carcinoma in vitro and in vivo
Gulden Menderes, Elena Bonazzoli, Stefania Bellone, Jonathan D. Black, Salvatore Lopez, Francesca Pettinella, Alice Masserdotti, Luca Zammataro, Babak Litkouhi, Elena Ratner, Dan-Arin Silasi, Masoud Azodi, Peter E. Schwartz, Alessandro D. Santin
Molecular profiling of gene copy number abnormalities in key regulatory genes in high-risk B-lineage acute lymphoblastic leukemia: frequency and their association with clinicopathological findings in Indian patients
Prerana Bhandari, Firoz Ahmad, Bibhu Ranjan Das
Prognostic significance of PD-L1 expression on tumor cells and tumor-infiltrating mononuclear cells in upper tract urothelial carcinoma
Bo Zhang, Wei Yu, Xueru Feng, Zheng Zhao, Yu Fan, Yisen Meng, Shuai Hu, Yun Cui, Qun He, Hong Zhang, Dong Li, Zhisong He, Liqun Zhou, Jie Jin, Wenke Han
Systematic review: isocaloric ketogenic dietary regimes for cancer patients
N. Erickson, A. Boscheri, B. Linke, J. Huebner
Targeting TDO in cancer immunotherapy
Cheng-Peng Yu, Yun-Lei Song, Zheng-Ming Zhu, Bo Huang, Ying-Qun Xiao, Da-Ya Luo
Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature
Icro Meattini, Isacco Desideri, Giulio Francolini, Agnese Vannini, Marco Perna, Pietro Garlatti, Roberta Grassi, Lorenzo Livi
Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy
Naoki Inui
Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer
Giuseppe Colloca, Antonella Venturino
Neoadjuvant treatment in pancreatic cancer: Evidence-based medicine? A systematic review and meta-analysis
Francesco D’Angelo, Laura Antolino, Alessio Farcomeni, Dario Sirimarco, Andrea Kazemi Nava, Martina De Siena, Niccolò Petrucciani, Giuseppe Nigri, Stefano Valabrega, Paolo Aurello, Giovanni Ramacciato
Feasibility of concurrent chemoradiotherapy with high-dose cisplatin after induction TPF chemotherapy in head and neck cancer: a critical review of the literature and the experience of the European Institute of Oncology
D. Alterio, M. Cossu Rocca, W. Russell-Edu, S. Dicuonzo, G. Fanetti, G. Marvaso, L. Preda, S. Zorzi, E. Verri, F. Nole’, B. A. Jereczek-Fossa
LincRNa-p21: function and mechanism in cancer
Shaoyun Chen, Hairong Liang, Hui Yang, Kairu Zhou, Longmei Xu, Jiaxian Liu, Bei Lai, Li Song, Hao Luo, Jianming Peng, Zhidong Liu, Yongmei Xiao, Wen Chen, Huanwen Tang
SAFE trial: an ongoing randomized clinical study to assess the role of cardiotoxicity prevention in breast cancer patients treated with anthracyclines with or without trastuzumab
Icro Meattini, Giuseppe Curigliano, Francesca Terziani, Carlotta Becherini, Mario Airoldi, Giacomo Allegrini, Domenico Amoroso, Sandro Barni, Carmelo Bengala, Valentina Guarneri, Paolo Marchetti, Francesca Martella, Pierluigi Piovano, Agnese Vannini, Isacco Desideri, Roberto Tarquini, Giorgio Galanti, Giuseppe Barletta, Lorenzo Livi
9p24 abnormalities in hematologic malignancies with a focus on diffuse large B-cell lymphoma
Dilan A. Patel, Andrew W. Hahn, Mike G. Martin
A statistical issue regarding the original paper by M. Tamiya and others (Med Oncol (2016) 33:2 DOI 10.1007/s12032-015-0715-7)
Hiroshige Yoshioka, Toshihiko Kaneda, Toshihide Yokoyama
Erratum to: Third-line treatment of colorectal liver metastases using DEBIRI chemoembolization
Germano Scevola, Giorgio Loreni, Marco Rastelli, Stefano Sposato, Sara Ramponi, Vittorio Miele
Vascular microinvasion from hepatocellular carcinoma: CT findings and pathologic correlation for the best therapeutic strategies
Alfonso Reginelli, Angelo Vanzulli, Cristiano Sgrazzutti, Luca Caschera, Nicola Serra, Antonio Raucci, Fabrizio Urraro, Salvatore Cappabianca
Radiofrequency versus microwave ablation for treatment of the lung tumours: LUMIRA (lung microwave radiofrequency) randomized trial
M. Macchi, M. P. Belfiore, C. Floridi, N. Serra, G. Belfiore, L. Carmignani, R. F. Grasso, E. Mazza, C. Pusceddu, L. Brunese, G. Carrafiello
Microwave ablation of malignant renal tumours: intermediate-term results and usefulness of RENAL and mRENAL scores for predicting outcomes and complications
Anna Maria Ierardi, Alessio Puliti, Salvatore Alessio Angileri, Mario Petrillo, Ejona Duka, Chiara Floridi, Michela Lecchi, Gianpaolo Carrafiello